• News

Published on April 19, 2022 by Jenny Maat

RheoCube is delighted to announce its three new Supervisory Board members. Willem Vaessen, Partner at Deloitte, will serve as Chairman. Jan-Frens van Giessel, Partner at Holland Capital, and Albert Stevens, Digital Transformation Director at IMCD, will also join the Board.

Jurjen van Rees, COO/CCO at RheoCube notes the value they will bring at this stage of the company’s evolution;

Appointing a Supervisory Board for a scientific software scale-up like RheoCube is actually quite a milestone. In particular, it’s exceptional to be able to appoint people like Willem, Albert and Jan-Frens, who are renowned industry experts. It proves that with RheoCube we’re onto something and that we are set to transform how R&D is done in the chemical industry. We are very excited and honored to have Willem, Albert and Jan-Frens join us on this journey.”

Willem Vaessen currently leads the Chemicals & Specialty Materials business at Deloitte. Previously, he held different operational roles in the chemical-pharmaceutical industry in Switzerland. He also served as an Executive Director of a digital technology vendor. He brings an extensive global network and a wealth of experience in digital transformations. Willem has an M.Sc. in Operations Research & Computer Science and a Ph.D. in Business Economics.

Jan-Frens van Giessel is a renowned venture and growth investor in healthcare and technology. In his role as Partner at Holland Capital, he focuses on investments in innovative fast-growing companies. Having led many investment rounds, Jan-Frens currently serves on the board of several portfolio companies of Holland Capital, such as HealthConnected (Health IT) and Sirius Medical (Medical Devices). 

Albert Stevens is the Group Director of Digital Transformation at IMCD N.V. He applies his skills and experience to the chemicals and ingredients industry. Albert is highly skilled in all aspects of digital transformation and strategy. His expertise spans many fields, including governance, operational excellence, artificial intelligence (AI), and mergers and acquisitions (M&A).

Jan Borgstädt of JOIN Capital will also provide supportive oversight to the board. The insights and guidance from these experts, alongside their deep industry experience will support the vision and work of the entire team. It will also enhance the ongoing development of RheoCube as a digital R&D solution that’s transforming product development cycles for companies around the world.

For more information on RheoCube, visit us on Linkedin or Twitter or contact a member of our team